LENZ 8-K 2026-07-02

LENZ Therapeutics, Inc. (LENZ) 8-K dated 2026-07-02 — accession 0001815776-26-000046. This URL is the filing, not the LENZ hub.

LENZ Therapeutics, Inc. (LENZ) is a biotechnology company listed on US.

LENZ Therapeutics, Inc. filed a 8-K on 2026-07-02. Accession 0001815776-26-000046.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LENZ revenue for 2025-12-31 was $19.1M. Net income was -$82.1M. LENZ currently screens at market cap $223.6M.

Not investment advice. The LENZ SEC hub lists recent forms. The stock page is the research view.